Evidence map›Paper›PMID 32418505›Full record

ArticleCirculation research2020

CITED4 Protects Against Adverse Remodeling in Response to Physiological and Pathological Stress.

Carolin Lerchenmüller, Charles P Rabolli, Ashish Yeri, Robert Kitchen, Ane M Salvador, Laura X Liu, Olivia Ziegler, Kirsty Danielson, Colin Platt, Ravi Shah and 10 more

Open access · greenAbstract read
In one paragraph

Article in Circulation research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 59 citations in OpenAlex.

  1. Article
  2. Article
  3. Exercise ModulatesInternational journal of molecular sciences · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. TargetingJournal of the American Heart Association · 2025
    Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. CITED4 gene therapy protects against maladaptive cardiac remodeling after ischemia/reperfusion injury in mice.Molecular therapy : the journal of the American Society of Gene Therapy · 2024
    Article
  20. Cited2 is a key regulator of placental development and plasticity.BioEssays : news and reviews in molecular, cellular and developmental biology · 2024
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors at 5 institutions in 3 countries.

Carolin LerchenmüllerFrom the Corrigan Minehan Heart Center and Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston (C.L., C.P.R., A.Y., R.K., A.M.S., L.X.L., O.Z., K.D., C.P., R.S., F.D., P.K., S.D., A.R.).
Charles P RabolliFrom the Corrigan Minehan Heart Center and Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston (C.L., C.P.R., A.Y., R.K., A.M.S., L.X.L., O.Z., K.D., C.P., R.S., F.D., P.K., S.D., A.R.).
Ashish YeriFrom the Corrigan Minehan Heart Center and Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston (C.L., C.P.R., A.Y., R.K., A.M.S., L.X.L., O.Z., K.D., C.P., R.S., F.D., P.K., S.D., A.R.).
Robert KitchenFrom the Corrigan Minehan Heart Center and Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston (C.L., C.P.R., A.Y., R.K., A.M.S., L.X.L., O.Z., K.D., C.P., R.S., F.D., P.K., S.D., A.R.).
Ane M SalvadorFrom the Corrigan Minehan Heart Center and Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston (C.L., C.P.R., A.Y., R.K., A.M.S., L.X.L., O.Z., K.D., C.P., R.S., F.D., P.K., S.D., A.R.).
Laura X LiuFrom the Corrigan Minehan Heart Center and Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston (C.L., C.P.R., A.Y., R.K., A.M.S., L.X.L., O.Z., K.D., C.P., R.S., F.D., P.K., S.D., A.R.).
Olivia ZieglerFrom the Corrigan Minehan Heart Center and Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston (C.L., C.P.R., A.Y., R.K., A.M.S., L.X.L., O.Z., K.D., C.P., R.S., F.D., P.K., S.D., A.R.).
Kirsty DanielsonFrom the Corrigan Minehan Heart Center and Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston (C.L., C.P.R., A.Y., R.K., A.M.S., L.X.L., O.Z., K.D., C.P., R.S., F.D., P.K., S.D., A.R.).
Colin PlattFrom the Corrigan Minehan Heart Center and Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston (C.L., C.P.R., A.Y., R.K., A.M.S., L.X.L., O.Z., K.D., C.P., R.S., F.D., P.K., S.D., A.R.).
Ravi ShahFrom the Corrigan Minehan Heart Center and Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston (C.L., C.P.R., A.Y., R.K., A.M.S., L.X.L., O.Z., K.D., C.P., R.S., F.D., P.K., S.D., A.R.).
Federico DamilanoFrom the Corrigan Minehan Heart Center and Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston (C.L., C.P.R., A.Y., R.K., A.M.S., L.X.L., O.Z., K.D., C.P., R.S., F.D., P.K., S.D., A.R.).
Piyusha KunduFrom the Corrigan Minehan Heart Center and Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston (C.L., C.P.R., A.Y., R.K., A.M.S., L.X.L., O.Z., K.D., C.P., R.S., F.D., P.K., S.D., A.R.).
Eva RiechertCardiology Department, University Hospital Heidelberg, Germany (C.L., E.R., H.A.K.).
Hugo A KatusCardiology Department, University Hospital Heidelberg, Germany (C.L., E.R., H.A.K.).
Jeffrey E SaffitzPathology Department, Beth Israel Deaconess Medical Center, Boston, MA (J.E.S.).
Hasmik KeshishianBroad Institute of MIT and Harvard, Cambridge, MA (H.K., S.A.C.).
Steven A CarrBroad Institute of MIT and Harvard, Cambridge, MA (H.K., S.A.C.).
Vassilios J BezzeridesCardiology Department, Boston Children's Hospital, MA (V.J.B.).
Saumya DasFrom the Corrigan Minehan Heart Center and Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston (C.L., C.P.R., A.Y., R.K., A.M.S., L.X.L., O.Z., K.D., C.P., R.S., F.D., P.K., S.D., A.R.).
Anthony RosenzweigFrom the Corrigan Minehan Heart Center and Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston (C.L., C.P.R., A.Y., R.K., A.M.S., L.X.L., O.Z., K.D., C.P., R.S., F.D., P.K., S.D., A.R.).
Harvard University · USBroad Institute · USHeidelberg University · DEBeth Israel Deaconess Medical Center · USBoston Children's Hospital · US

Funding

The Harvard Clinical and Translational Science CenterUL1TR002541 · NCATS · HARVARD MEDICAL SCHOOL · PI NADLER, LEE MARSHALL · 2018 to 2022
$93.0M
Understanding the Cardiac Benefits of Exercise at the Cellular and Molecular LevelR35HL155318 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ANTHONY ROSENZWEIG · 2021 to 2026
$5.4M
Role of Activin Type II receptor signaling in age-related heart failureR01AG061034 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ROSENZWEIG, ANTHONY · 2019 to 2023
$3.0M
The role of C/EBPbeta and CITED4 in the heartR01HL110733 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI ROSENZWEIG, ANTHONY · 2011 to 2015
$2.1M
Novel Role for Circulating extracellular RNAs in Human Heart FailureR01HL122547 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI DAS, SAUMYA · 2015 to 2019
$2.1M
Does Exercise Induce Cardiomyogenesis?R01HL122987 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI ROSENZWEIG, ANTHONY · 2014 to 2018
$1.7M
Role of miR-222 in pathological hypertrophy and heart failureR01HL135886 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI ROSENZWEIG, ANTHONY · 2017 to 2020
$1.7M
Discovery and characterization of lncRNAs involved in cardiac exercise phenotypesR01HL146464 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI ROSENZWEIG, ANTHONY · 2020 to 2020
$400k
NCATS NIH HHS UL1 TR002541NHLBI NIH HHS R01 HL110733NHLBI NIH HHS R01 HL122547NHLBI NIH HHS R01 HL122987NHLBI NIH HHS R01 HL135886NHLBI NIH HHS R01 HL146464NHLBI NIH HHS R35 HL155318NIA NIH HHS R01 AG061034
6 · The paper itself

Abstract

rationaleCardiac CITED4 (CBP/p300-interacting transactivators with E [glutamic acid]/D [aspartic acid]-rich-carboxylterminal domain4) is induced by exercise and is sufficient to cause physiological hypertrophy and mitigate adverse ventricular remodeling after ischemic injury. However, the role of endogenous CITED4 in response to physiological or pathological stress is unknown.

objectiveTo investigate the role of CITED4 in murine models of exercise and pressure overload. METHODS AND

resultsWe generated cardiomyocyte-specific CITED4 knockout mice (C4KO) and subjected them to an intensive swim exercise protocol as well as transverse aortic constriction (TAC). Echocardiography, Western blotting, qPCR, immunohistochemistry, immunofluorescence, and transcriptional profiling for mRNA and miRNA (microRNA) expression were performed. Cellular crosstalk was investigated in vitro. CITED4 deletion in cardiomyocytes did not affect baseline cardiac size or function in young adult mice. C4KO mice developed modest cardiac dysfunction and dilation in response to exercise. After TAC, C4KOs developed severe heart failure with left ventricular dilation, impaired cardiomyocyte growth accompanied by reduced mTOR (mammalian target of rapamycin) activity and maladaptive cardiac remodeling with increased apoptosis, autophagy, and impaired mitochondrial signaling. Interstitial fibrosis was markedly increased in C4KO hearts after TAC. RNAseq revealed induction of a profibrotic miRNA network. miR30d was decreased in C4KO hearts after TAC and mediated crosstalk between cardiomyocytes and fibroblasts to modulate fibrosis. miR30d inhibition was sufficient to increase cardiac dysfunction and fibrosis after TAC.

conclusionsCITED4 protects against pathological cardiac remodeling by regulating mTOR activity and a network of miRNAs mediating cardiomyocyte to fibroblast crosstalk. Our findings highlight the importance of CITED4 in response to both physiological and pathological stimuli.

Indexed as

Cardiomegaly, Exercise-InducedVentricular Function, LeftVentricular RemodelingAnimalsCell CommunicationCells, CulturedDisease Models, AnimalFibroblastsFibrosisGene Expression RegulationHeart FailureHypertrophy, Left VentricularMaleMice, KnockoutMicroRNAsMyocytes, CardiacCited4 protein, mouseMicroRNAsMirn30d microRNA, mousemTOR protein, mouseTOR Serine-Threonine KinasesTranscription Factorsexerciseextracellular matrixheart failuresignal transduction

Identifiers

PMID32418505
PMCPMC7725361
OpenAlexW3026255765

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.